A new CTN study investigates how exposure to HIV and antiretroviral drugs during pregnancy could have long-term effects for the millions of kids who were born to mothers living with HIV, but who did not acquire the virus themselves
The CTNPT 024 team investigated whether vitamin E could be a treatment option for NASH, a type of liver disease that is more common among people living with HIV
The WHO-funded study shows that dolutegravir is the optimal choice for first-line treatment of HIV
Our Resource Library is a place to share documents, videos, and training resources about HIV and STBBI research and related topics.
The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.
Exploring the role of the soluble glycoprotein 120 as a pan-toxin driving immune dysfunction and accelerated aging in people living with HIV
Interplay between expanded endocannabinoid (eCB) system and inflamm-aging: Implication for accelerated atherosclerosis in people living with HIV (PLWH) under ART
Influence of a 3-month letermovir treatment on gut inflammation in ART-treated HIV-infected persons in an open labelled controlled randomized study
Drug-drug interaction study between bictegravir/emtricitabine/tenofovir alafenamide and feminizing hormones in trans women living with HIV
Electronic capture through the Opal patient portal of a patient-reported measure of barriers to antiretroviral therapy adherence: a mixed method type 3 hybrid pilot study at a large Montreal HIV clinic
Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.